Mitochondria are the most abundant organelles in mammalian oocytes and early embryos. Mitochondrial DNA (mtDNA) mutations, including the common deletion, have been found in skeletal muscle fibres from aged rhesus macaques. The specific aims of this study were to determine whether the mitochondrial common deletion is present in rhesus oocytes after hormonal stimulation and in embryos generated by in vitro production, or whether this deletion is already present in the immature oocyte. Using a nested primer PCR strategy, we found a significant increase in the proportion of mtDNA deletions in stimulated oocytes and embryos from rhesus macaques, compared with mtDNA deletions in immature, unstimulated oocytes derived from necropsied ovaries of age-matched monkeys. The common deletion is larger in the rhesus (5704 bp) than in humans (4977 bp). Accumulation of mtDNA deletions in oocytes may contribute to mitochondrial dysfunction and impaired ATP production. We propose the rhesus to be an excellent model to assess the quality of gametes and embryos and their developmental competence in primates, including humans.
Introduction
Understanding why a high proportion of seemingly normal oocytes cause developmentally incompetent embryos following in vitro fertilization (IVF) is a high priority for infertility clinics. Human IVF preimplantation embryos show high frequencies of abnormal development and early demise, with further losses seen after intrauterine transfer, when measured by outcome per embryo. One hypothesis is that mitochondrial dysfunctions or genetic anomalies in the oocyte may be critical determinants of developmental competence of the embryo (Barritt et al., 2000b; Van Blerkom, 2004; May-Panloup et al., 2005) . More than 150 mitochondrial DNA (mtDNA) rearrangements, including deletions, insertions and duplications have been identified in various somatic cells (Wallace, 1993) . These mutations are responsible for many catastrophic neuromuscular diseases such as Kearns-Sayre syndrome (KSS), chronic progressive external ophthalmoplegia (CPEO) and Pearson's syndrome. mtDNA rearrangements also accumulate with age and can become more prevalent in postmitotic tissues (Cortopassi and Arnheim, 1990) . Slow and non-dividing cells such as neurons, skeletal muscle and oocytes appear to harbour a higher percentage of mitochondrial mutations than rapidly dividing cells, possibly due to the proximity of mtDNA to highly mutagenic reactive oxygen species (ROS) generated in the mitochondria (Brenner et al., 1998) . Perhaps, these mutations are due to the lack of mitochondrial repair activity by the DNA polymerase gamma (Polγ) during oogenesis (Trifunovic et al., 2004) .
Although a direct relationship between mitochondrial mutations in oocytes and embryos and reproductive success has not been demonstrated, it is generally assumed that there must be a sufficient number of functional mitochondrial genomes in the embryo to develop and implant successfully (May-Panloup et al., 2005) . A high proportion of genetically abnormal mitochondria in the oocyte could potentially reduce the number of functional mitochondria, leading to embryonic arrest, failed implantation or mitochondrial disease.
Among the mitochondrial mutations that have been described in humans, one that is termed the 'common deletion' or ΔmtDNA4977 entails the deletion of 4977 bp (Chen et al., 1995; Keefe et al., 1995; Brenner et al., 1998; Barritt et al., 1999) . This mutation can be detected at frequencies as high as 30-50% in human oocytes, although its frequency appears to be considerably lower in embryos that are generated from the same cohorts of oocytes (Brenner et al., 1998; Barritt et al., 1999) . This is intriguing, considering that surplus embryos available for analysis in clinical IVF programs are generally classified as developmentally defective. Aside from the ΔmtDNA4977 deletion, an additional 23 novel mtDNA rearrangements have been described in human oocytes and embryos (Barritt et al., 1999) . Using a nested PCR strategy, mtDNA rearrangements can be detected in 51 and 32% of human oocytes and embryos, respectively. Multiple rearrangements were detected in 31% of oocytes and 14% of embryos. Other studies show that oocyte-specific mutations predominate in the regulatory control region of the mitochondrial genome (Barritt et al., 2000a,b) . Age-dependent accumulations of these mutations in the mitochondrial control region may be responsible for impaired transcription and regulated replication of mitochondria in oocytes from older women (Michikawa et al., 1999; Barritt et al., 2000b) . These data provide intriguing insights into mitochondrial mutations and ageing in the human female gamete that warrant further investigation in appropriate primate models. Support for an age-dependent increase in mitochondrial mutations comes from studies of skeletal muscle in rhesus macaques that not only showed the presence of the ΔmtDNA4977 deletion but also revealed that multiple deletions existed in all animals older than 13 years. In some cases, the deletions were so extensive that large portions of the mitochondrial genome were missing (Schwarze et al., 1995; Lopez et al., 2000; Mehmet et al., 2001) . The specific aims of this study, therefore, were to determine whether the mitochondrial common deletion is present in immature and mature non-human primate oocytes and in embryos generated by IVF.
Materials and methods

Ovarian stimulation, oocyte recovery and IVF
All animals were used with approval of the Tulane University's Institutional Animal Care and Use Committee. Ovarian stimulation and oocyte recovery were performed as previously described by Schramm et al. (2002) . Briefly, females were observed for signs of menstrual activity and were subjected to follicular stimulation through intramuscular injections of recombinant human FSH over an 8 day period. On the 9th day of FSH injections, the animal was injected with recombinant hCG. Cumulus-oocyte complexes were collected from anesthetized animals by laparoscopic follicular aspiration (27-30 h post-HCG) and placed in HEPES buffered TALP (modified Tyrode's albumin lactate pyruvate medium) (Bavister et al., 1983) at 37°C. The cohort of oocytes was randomly split into two groups that were either immediately used for mtDNA analysis or subjected to IVF. Oocytes to be fertilized were transferred to equilibrated CMRL medium (Gibco Cell Culture, Invitrogen, Carlsbad, CA, USA) in oil with 5% CO 2 at 37°C.
Rhesus semen was collected by penile electroejaculation as described by Lanzendorf et al. (1990) . Following liquefaction for 15 min at room temperature, the sample was washed twice in TALP-HEPES by centrifugation for 7 min at 350 g. Sperm count and motility analyses were performed and the spermatozoa were resuspended in TALP-HEPES; then the sperm suspension was stored at room temperature. Approximately 1 h before insemination, spermatozoa were exposed to 1 mM dibutyryl cyclic adenosine 3′, 5′-monophosphate (dbcAMP) and 1 mM caffeine for sperm activation (Bavister et al., 1983) .
For IVF, oocytes were inseminated with 5 × 10 4 activated spermatozoa and cultured in 50 μl drops of CMRL at 37°C in 5% CO 2 . Oocytes were examined 10-16 h postinsemination for the presence of pronuclei. Oocytes with pronuclei were cultured for 48 h (to approximately the 8-cell stage) in HECM-9 (Bavister et al., 1983) .
DNA purification
Embryos and oocytes (denuded of cumulus cells using 10 mg/ml hyaluronidase dissolved in TL-HEPES) were stripped of their zonae pellucidae with acid Tyrode's solution (Sigma-Aldrich, St. Louis, MO, USA). They were individually placed into 0.2 ml PCR tubes with 3 μl of 0.1% polyvinyl alcohol (PVA) in phosphate-buffered saline (PBS). Samples were stored at −20°C until use. Before PCR, 3 μl of a mixture of 4 × 10 -4 M sodium dodecyl sulphate (SDS; Sigma-Aldrich) and 125 μg/ml proteinase K (Roche Diagnostics Corp., Indianapolis, IN, USA) was added to each tube for cell lysis. The tubes were incubated at 37°C for 1 h and then heated to 95°C for 15 min to inactivate proteinase K.
The gene-specific oligonucleotide primers used in this study were synthesized by Sigma Genosys (The Woodlands, TX, USA). To amplify the internal control mtDNA region and the rhesus common deletion simultaneously, the DNA was divided into two 3 μl aliquots before PCR amplification. Each aliquot was amplified using a MyCycler Thermal Cycler (Bio-Rad, Hercules, CA, USA) in a 25 μl reaction volume containing 1.5 mM MgCl 2 , 1 IU Taq polymerase, 200 μM each dNTP and 0.5 μM gene-specific primers using the following amplification profile: 1 cycle at 95°C for 1 min; 30 cycles at 95°C for 25 s; 62°C for 25 s and 72°C for 2 min; followed by 1 cycle at 72°C for 5 min and then a hold at 4°C. For the nested PCR, 3 μl of the first reaction served as a template. The nested PCR was performed using the following profile: 1 cycle at 95°C for 1 min; 40 cycles at 95°C for 25 s; 62°C for 25 s then 72°C for 2 min followed by 1 cycle at 72°C for 5 min and then a hold at 4°C. The evaluation of PCR results was performed by agarose gel electrophoresis. Eight microlitres of nested PCR product and 2 μl of blue/orange loading dye were separated on 1.5% gel and stained with ethidium bromide. The positive control for the rhesus common deletion was DNA isolated from skeletal muscle derived from a 31-year-old male rhesus macaque, amplified under the same conditions as the oocytes and embryos.
PCR detection of the rhesus common deletion
To detect the rhesus common deletion, a nested PCR strategy was applied. Oligonucleotide sequences were taken from mtDNA sequence analysis by Schwarze et al. (1995) . PCR primers were designed based on the corresponding sites in the human mtDNA genome. Primer sequences and corresponding human mtDNA positions are summarized in Table I . Primers RhM15.1 and RhM15.6 were used for amplification of a 599 bp internal control mtDNA amplicon. Primers RhM15.1 and RhM7.2 were used in combination with RhM14.8 and RhM8966 using a nested PCR strategy to detect the rhesus common deletion as shown in Figure 1 .
Statistical analysis
A 2 × 2 G-test was performed to determine significant differences between percentages of non-stimulated oocytes versus stimulated oocytes; non-stimulated oocytes versus stimulated, unfertilized oocytes; non-stimulated oocytes versus IVF embryos and all non-stimulated versus stimulated oocytes and embryos. The statistical formula used was where P 1 and P 2 are the percent frequencies of the two groups being compared; n 1 and n 2 are respective sample sizes and 820.1 is a constant representing the parametric variance of a distribution of arcsine transformations of percentages . The arcsine is the angle, in degrees, whose sine corresponds to the value given and was determined from published tables ). The t s values were compared to critical values of Student's t-distribution using a two-tailed distribution.
Results
Characterization of the rhesus mitochondrial common deletion
To validate the assay for the detection of the rhesus common deletion, the nested PCR strategy shown in Table I and Figure 1 was employed. Primers RhM15.1 and RhM15.6 were used to amplify DNA isolated from skeletal muscle tissue of a 31-year-old rhesus macaque. A 599 bp internal positive mtDNA control was observed in duplicate (Figure 2,  lanes 1 and 2) . The rhesus mitochondrial common deletion was amplified from the same tissue and showed a 180 bp fragment (Figure 2,  lanes 3 and 4) . DNA sequencing of the 180 bp amplicon demonstrated that a 5703 bp deletion occurred in the rhesus mitochondrial genome. Using a nested PCR as described in materials and methods, the remaining 180 bp amplicon is the result of the deletion of the 5703 bp, as shown in Figure 1 .
Mitochondrial deletions in immature oocytes
Using the same nested PCR strategy, 127 immature oocytes excised from necropsied ovaries (n = 13 animals) were examined for the presence of the rhesus common deletion. Only 27 of the 127 oocytes contained this deletion (21.3%). The amplification efficiency was over 90%. The intensity of the amplified PCR product varied, indicating different copy numbers of mtDNA among the oocytes analyzed. Skeletal muscle tissue from a 31-year-old monkey served as a positive control and showed the same 180 bp amplicon illustrated in Figure 2 .
Mitochondrial deletions in non-human primate oocytes and embryos
Using the same PCR amplification strategy, we tested for the presence of the common deletion in 22 metaphase II (MII) oocytes (n = 4 animals), 17 oocytes that failed to fertilize (n = 3 animals) and 31 day three embryos (n = 6 animals) were tested for presence of the common deletion. Surprisingly, 77.3% of the stimulated MII oocytes, 70.6% of failed fertilized oocytes and 67.7% of the embryos harboured this mutation (Table II) . Figure 3A (lanes 1-13) shows the positive mitochondrial control 599 bp amplicon from each oocyte and embryo. Figure 3B (lanes 1, 2, 4-6, 9 and 10) shows the 180 bp common deletion. This mitochondrial deletion was not present in every oocyte and embryo in Figure 3B (lanes 3, 7, 8 and 11-13 ). There was a substantial difference in the band intensity of the common deletion in oocytes and embryos. In addition, faint PCR products were observed with both the positive internal mitochondrial control primers and the nested primers.
Comparison of non-stimulated oocytes and stimulated oocytes and embryos that harbour the mitochondrial deletions
In the non-stimulated oocytes, 21.3% (27/127) contained the mitochondrial common deletion compared with a frequency of 71.4% (50/70) in stimulated oocytes and embryos (P < 0.001, Tables II and III, Figure 4 ). Additionally, there was a statistically significant difference (P < 0.001) in the ratio of this mutation between non-stimulated oocytes and mature MII oocytes, embryos and oocytes that failed to fertilize as a group.
Discussion
Over 100 mitochondrial mutation-associated diseases have been identified. In addition, the accumulation of mtDNA deletions has been found in brain, cardiac muscle, skeletal muscle and liver. It was imperative that the initial mtDNA analysis be done using somatic tissue, such as skeletal muscle, as the comparative baseline for mtDNA candidates in non-human primate oocytes and embryos. Skeletal muscle biopsies collected at 3 year intervals in rhesus macaques suggest that the increasing frequencies of mtDNA deletions are correlated with increasing age (Gokey et al., 2004) . To determine if the common mutation (ΔmtDNA4977) exists in rhesus macaques, a nested PCR strategy was applied in this study using skeletal muscle of a 31-year-old monkey. Analysis by PCR generated a 180 bp PCR DNA fragment, rather than the 930 bp amplicon observed in human mtDNA (Figure 2, lanes 3 and 4) . This indicates that the common Figure 2 . The rhesus common deletion was generated using DNA isolated from 31-year-old rhesus skeletal muscle. Nested PCR products were separated on 1.2% agarose gel and stained with ethidium bromide. Lane M, 100 bp DNA ladder. Lanes 1 and 2 demonstrate the internal control region amplified with primers RhM15.6 and RhM15.1 showing a 599 bp band. Lanes 3 and 4 show the rhesus common deletion 180 bp amplicon generated using primers RhM15.1 and RhM7.2 followed by RhM14.8 and RhM8966. deletion in rhesus monkeys entails the loss of 5703 base pairs, which is considerably larger than the 4977 common deletion typically found in human KSS patients. One reason for this discrepancy might be that the rhesus mitochondrial genome has only 80.4% nucleotide sequence homology with the human mitochondrial genome and may contain altered sites of preferential replication errors (Gokey et al., 2004) . Using the same nested PCR strategy shown in Figure 1 , 127 immature oocytes and 70 stimulated oocytes and IVF embryos were evaluated for the rhesus mitochondrial common deletion (Tables II and III) . It was surprising to find that the frequency of this mtDNA mutation in immature germinal vesicle (GV) oocytes excised from necropsied ovaries was low (21.3%) when compared with gonadotrophin-stimulated MII oocytes and embryos (71.4%). The precise mechanisms responsible for this increase are unknown. It has been suggested that there is a massive amplification of the mitochondrial genome during the process of oogenesis, presumably to support the initial period of embryonic development. The average mtDNA copy number of the human MII oocyte has been estimated to be 795 000 (±243 000) (Barritt et al., 2002) . However, it is not known whether the number of mtDNA molecules remains stable during primate preimplantation development.
It has recently been suggested that mitochondrial replication occurs during a very short period from the 1-to 2-cell stage in the mouse embryo before fertilization (McConnell and Petrie, 2004) . It is therefore unclear when mitochondrial transcription and replication actually begin in primate oocytes and embryos. It has been shown that preimplantation mouse embryos are dependent upon the energy produced from mitochondria derived solely from the oocytes and that mitochondrial replication does not occur until the blastocyst stage (Piko and Taylor, 1987; Smith and Alcivar, 1993) . In fact, the mtDNA copy numbers remain remarkably stable throughout preimplantation development. Moreover, it has been reported that there is a high variability of mtDNA copy numbers among individual mouse blastocysts, suggesting that some embryos may be able to initiate mtDNA replication before implantation (Thundathil et al., 2005) . This shows a significant increase in the mtDNA common deletion in stimulated rhesus MII oocytes and embryos. This also implies that mitochondrial replication must occur during either exogenous gonadotrophin stimulation and/or during oocyte maturation.
The mechanisms that regulate mitochondrial replication and function during oogenesis and preimplantation development are largely unknown but must be dependent on nuclear-encoded factors, such as mitochondrial transcription factor (Tfam), nuclear respiratory factor 1 (Nrf1), mitochondrial RNA polymerase (Polmt) and mitochondrial transcription factor B1 (Tfb1m) and B2 (Tfb2m). We are currently investigating the molecular control of mitochondrial transcription and replication during production of IVF preimplantation embryos. It is unknown how mitochondrial replication processes might generate mitochondrial deletions and point mutations in ageing tissues or non-dividing cells such as oocytes. One theory is that ROS, in the vicinity of the mtDNA, can cause both single-stranded and double-stranded breaks before Tfam binds to and stabilizes the mtDNA (Trifunovic et al., 2004) .
It has long been assumed that all of the mitochondria in the mature MII oocyte arise from the clonal expansion of an extremely small number of mitochondria during oogenesis, but it has never been determined precisely when these events take place (Van Blerkom, 2004) . Perhaps during the clonal expansion of these mitochondria, the rapidity of the replication process causes mtDNA defects. Recent data show that oocyte ATP content increases significantly during porcine in vitro maturation (IVM), similar to what has been reported in the cow Figure 3 . Rhesus control mitochondrial DNA (mtDNA) and common deletion in rhesus gonadotrophin-stimulated oocytes and day 3 embryos. Lane M, 100 bp ladder. A, lanes 1-6 demonstrate the internal control region amplified with primers RhM15.6 and RhM15.1 showing a 599 bp band in stimulated oocytes. Lanes 7-13 in A show a 599 bp band control amplicon in IVF day 3 embryos. B, lanes 1, 2 and 4-9 show the rhesus common deletion or 180 bp amplicon generated in stimulated oocytes or day 3 embryos using primers RhM15.1 and RhM7.2 followed by RhM14.8 and RhM8966. (Stojkovic et al., 2001; Brevini et al., 2005) . These data suggest that mitochondrial replication must occur during porcine and bovine IVM and are consistent with our data for the rhesus. The most logical explanation for the high frequency of mtDNA defects in oocytes from gonadotrophin-stimulated humans and nonhuman primates (Chen et al., 1995; Keefe et al., 1995; Brenner et al., 1998; Barritt et al., 1999;  and this study) is that administration of high doses of exogenous FSH recruits many more follicles than in a natural cycle, so that numerous defective oocytes that were destined for atresia are aspirated along with normal oocytes. As a corollary, the proportion of oocytes with mtDNA defects increases in older primates because most of the 'good' oocytes with normal mtDNA have already been recruited. If this were true, then we would expect GV stage oocytes in unstimulated ovaries to contain a high incidence of mtDNA defects, which would not change much, if at all, following gonadotrophin stimulation. However, our data contradict this explanation. We found that the frequency of mtDNA defects (the common deletion) was relatively low (21%) in GV oocytes from unstimulated rhesus ovaries, but increased more than three-fold (71%) in oocytes from follicles recruited using FSH stimulation. This result suggests an entirely different scenario: that the administration of exogenous FSH actually causes the mtDNA defects in oocytes. Moreover, our data indicate that there must be substantial mtDNA replication during oocyte recruitment, either at the GV stage over 8 days of FSH stimulation and/or during approximately 30 h following hCG administration during resumption of meiosis. Either way, if this explanation is correct, it would mandate a complete re-evaluation of the gonadotrophin stimulation regimen used in human infertility clinics. It is very unlikely that the answers can be found from human clinical data because of the inherent priority to obtain pregnancy rather than to examine different gonadotrophin stimulation approaches. Instead, the etiology of mtDNA defects in primate oocytes must be examined using non-human primates, such as the rhesus monkey, in which experiments can be designed to specifically evaluate possible effects of gonadotrophin stimulation on oocyte quality and competence. Such experiments are in progress in our laboratory to determine if extensive mitochondrial damage occurs during gonadotrophin stimulation and if this damage can be repaired through the nuclear mitochondrial transcription factor Polγ during early primate embryo development.
